Your browser doesn't support javascript.
loading
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
Groome, Michelle J; Fairlie, Lee; Morrison, Julie; Fix, Alan; Koen, Anthonet; Masenya, Maysseb; Jose, Lisa; Madhi, Shabir A; Page, Nicola; McNeal, Monica; Dally, Len; Cho, Iksung; Power, Maureen; Flores, Jorge; Cryz, Stanley.
Afiliación
  • Groome MJ; South African Medical Research Council (SAMRC): Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation (DST/NRF): Vaccine Preventable Diseases, Facul
  • Fairlie L; Wits Reproductive Health and HIV Institute, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Morrison J; Family Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.
  • Fix A; PATH, Washington, DC, USA.
  • Koen A; South African Medical Research Council (SAMRC): Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation (DST/NRF): Vaccine Preventable Diseases, Facul
  • Masenya M; Wits Reproductive Health and HIV Institute, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Jose L; South African Medical Research Council (SAMRC): Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation (DST/NRF): Vaccine Preventable Diseases, Facul
  • Madhi SA; South African Medical Research Council (SAMRC): Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation (DST/NRF): Vaccine Preventable Diseases, Facul
  • Page N; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • McNeal M; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Dally L; The Emmes Corporation, Rockville, MD, USA.
  • Cho I; PATH, Washington, DC, USA; Novavax, Gaithersburg, MD, USA.
  • Power M; PATH, Washington, DC, USA.
  • Flores J; PATH, Washington, DC, USA.
  • Cryz S; PATH, Washington, DC, USA.
Lancet Infect Dis ; 20(7): 851-863, 2020 07.
Article en En | MEDLINE | ID: mdl-32251641

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rotavirus / Vacunas de Subunidad / Vacunas contra Rotavirus / Relación Dosis-Respuesta Inmunológica / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Africa / America do norte Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rotavirus / Vacunas de Subunidad / Vacunas contra Rotavirus / Relación Dosis-Respuesta Inmunológica / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Africa / America do norte Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article